First Eagle Investment Management
XGN icon

First Eagle Investment Management’s Exagen XGN Stock Holding History

First Eagle Investment Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Buy
306,965
+181,723
+145% +$684K ﹤0.01% 350
2026
Q1 		$376K Buy
+125,242
New +$484K ﹤0.01% 380

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

First Eagle Investment Management's XGN Position: Q2 2026 in Review

First Eagle Investment Management increased its Exagen (XGN) stake by 145% in Q2 2026, buying an estimated $684K and bringing the position to 306,965 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #350.

First Eagle Investment Management first reported a position in XGN in Q1 2026 and has held it in 2 quarters since. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • First Eagle Investment Management held 306,965 shares of Exagen worth $1.43M as of Q2 2026.
  • First Eagle Investment Management bought 181,723 Exagen shares in Q2 2026, an estimated $684K.
  • Exagen made up ﹤0.01% of First Eagle Investment Management's portfolio in Q2 2026, its #350 holding.
  • First Eagle Investment Management first reported a position in Exagen in Q1 2026 and has held it in 2 quarters since.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on First Eagle Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.